(Circulation. 2000;101:e9033.)
© 2000 American Heart Association, Inc.
Cardiovascular News |
New Era for Ventricular Devices
Surgeons at the Texas Heart Institute in Houston implanted the
Jarvik 2000 in a 52-year-old woman with
cardiomyopathy, signaling a new era for
ventricular assist devices (VADs). The Jarvik 2000
(Figure
) is a small, battery-powered axial flow pump
that can be used in smaller patients whose bodies are not large enough
to accommodate the larger VADs currently approved for use.
|
O.H. Frazier, MD, codirector of Cullen Cardiovascular Research Laboratories and the chief of cardiopulmonary transplantation at the Texas Heart Institute, implanted the thumb-sized pump in the womans chest on April 10 under a protocol approved by the US Food and Drug Administration (FDA). The implant surgery was observed by Stephen Westaby, MD, and his clinical research team from Oxford, UK. The Oxford group initiated a collaborative research project with Drs Jarvik and Frazier in recent years. The FDA has tentatively approved the use of the new small heart-assist device as a bridge to transplant in 5 patients. Dr Frazier said the new pump has many advantages for a variety of patients.
In smaller patients, the pump, which is about the size of a "C"
battery, offers a chance to unload the burden on the heart. The
miniature intraventricular axial flow pump is only
25 cm3 in volume and weighs 90 g. In this
case, Dr Frazier put the Jarvik 2000 in through the left chest rather
than the midline, and the patient lost only
200 mL of blood, which
is
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |